Company Overview
About ConcertAI
ConcertAI is a Boston-based company that combines artificial intelligence with real-world oncology data to accelerate cancer drug development and improve patient outcomes. Its platform integrates multi-modal patient data — including electronic health records, genomics, imaging, and pathology — from a network of oncology providers to support biopharma companies in clinical trial design, site selection, protocol optimization, patient matching, and regulatory submission.
Business Model & Competitive Advantage
The company acquired CancerLinQ from the American Society of Clinical Oncology (ASCO) in December 2023, expanding its real-world data (RWD) assets to 5.5 million multi-modal oncology patient records — the largest curated oncology RWD repository in the US. ConcertAI has raised over $230 million including a $150 million Series C in March 2022 at a $1.9 billion valuation, with investors including SoftBank Vision Fund 2. The company exited FY2024 profitable, reporting mid-teens unadjusted EBITDA margins and the highest annual recurring revenue (ARR) ratio in company history at 72%.
Competitive Landscape 2025–2026
ConcertAI's CARAai platform powers its data-as-a-service (DaaS) and AI SaaS offerings, with an expanding collaboration with NVIDIA in medical imaging announced for 2025. The company serves 40+ biopharma clients and regulatory bodies, positioning itself as the connective intelligence layer between oncology real-world evidence and the clinical and regulatory decisions that bring cancer treatments to patients.
Key Differentiators
Market Leader
ConcertAI is recognized as a market leader in the Life Sciences & BioTech sector, demonstrating strong industry presence and customer trust.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
Saama Analytics
Saama Analytics is the leading AI-driven clinical analytics and data management platform for the life sciences industry, positioning itself as the "#1 in AI Clinical Analytics" based on customer adopt
DNAnexus
DNAnexus is the category-defining cloud platform for precision health data management, analysis, and collaboration. Founded in 2009 and headquartered in Mountain View, California, DNAnexus provides a
Schrödinger
Schrödinger was founded in 1990 by Richard Friesner and David Pearlman in New York City, building physics-based computational methods for molecular simulation. For over 30 years the company has develo
Tempus
Tempus AI is a technology company applying artificial intelligence to advance precision medicine across oncology, neurology, psychiatry, and cardiology. Founded in 2015 by Eric Lefkofsky (co-founder o
Florence Healthcare
Florence Healthcare is the dominant software platform for clinical trial site enablement, providing digital tools that connect trial sites, sponsors, and contract research organizations (CROs) to stre
Emulate
Emulate, Inc. is a Boston-based biotechnology company that designs, manufactures, and commercializes Organ-Chip technology — micro-engineered devices lined with living human cells that replicate the m
Compare ConcertAI with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from ConcertAI? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim ConcertAI Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention ConcertAI vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →